Skip to content
TrialScanner

NCT03655756

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Early Phase 1CompletedHURALead

Registry record

Lead sponsor
TuHURA Biosciences, Inc.
Conditions
Cutaneous Melanoma, Stage III; Cutaneous Melanoma, Stage IV
Primary completion
Jul 10, 2020Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03655756 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03655756: pDNA Intralesional Cancer... | TrialScanner